Cardima, Inc. Receives Chinese State Food and Drug Administration (SFDA) Approval to Market the INTELLITEMP(R) Energy Management Device in the People’s Republic of China

FREMONT, CA--(Marketwire - June 30, 2008) - Cardima, Inc. (OTCBB: CADM) Cardima has been granted a market access license for the INTELLITEMP® by the SFDA and it is the first multichannel radiofrequency (RF) energy delivery device to receive approval for sale in China. The Company was previously awarded an INTELLITEMP patent by the State Intellectual Property Office in 2003.

MORE ON THIS TOPIC